Azacitidine Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Azacitidine Injection (injection) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Dec 22, 2020. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Teva Pharmaceuticals USA, Inc.
- Package NDC
- 68001-313-56
- Dosage Form
- Injection
- Presentation
- Azacitidine, Injection, 100 mg (NDC 68001-313-56)
- Initial Posting
- Dec 22, 2020
Reason
Other